KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Other financing activities (2016 - 2019)

Historic Other financing activities for Neogenomics (NEO) over the last 8 years, with Q4 2019 value amounting to $8000.0.

  • Neogenomics' Other financing activities changed N/A to $8000.0 in Q4 2019 from the same period last year, while for Dec 2020 it was $105000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.1 million for FY2019, which is 9971.55% down from last year.
  • Latest data reveals that Neogenomics reported Other financing activities of $8000.0 as of Q4 2019.
  • In the past 5 years, Neogenomics' Other financing activities registered a high of $576000.0 during Q2 2018, and its lowest value of -$112000.0 during Q3 2017.
  • Over the past 4 years, Neogenomics' median Other financing activities value was $97000.0 (recorded in 2016), while the average stood at $129666.7.
  • Within the past 5 years, the most significant YoY rise in Neogenomics' Other financing activities was 1546.39% (2017), while the steepest drop was 1546.39% (2017).
  • Over the past 4 years, Neogenomics' Other financing activities (Quarter) stood at $97000.0 in 2016, then tumbled by 215.46% to -$112000.0 in 2017, then soared by 614.29% to $576000.0 in 2018, then tumbled by 98.61% to $8000.0 in 2019.
  • Its last three reported values are $8000.0 in Q4 2019, $97000.0 for Q3 2019, and $576000.0 during Q2 2018.